Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases

Krumme D, Wenzel H, Tschesche H (1998)
FEBS LETTERS 436(2): 209-212.

Journal Article | Published | English

No fulltext has been uploaded

Abstract
Novel peptides containing the sequence -Pro-Leu-Ama(NHOH)- were synthesized and characterized by spectroscopic techniques. Their inhibitory properties towards the activated form of native human gelatinase B (MMP-9) and the catalytic domain of neutrophil collagenase (cdMMP-8) were determined. The most effective inhibitor synthesized exhibits K-i values of 2 x 10(-6) Il I (cdMMP-8) and 5 x 10(-9) RI (MMP-9) thus attaining interesting discrimination between the tested metalloproteinases. A most important feature of this type of inhibitor is its peptide nature making the compounds similar to natural substrates. In spite of the peptide character of the inhibitors synthesized, the P-1-P-1'-peptide bond shows a high resistance to cleavage by the proteinases. (C) 1998 Federation of European Biochemical Societies.
Publishing Year
ISSN
PUB-ID

Cite this

Krumme D, Wenzel H, Tschesche H. Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases. FEBS LETTERS. 1998;436(2):209-212.
Krumme, D., Wenzel, H., & Tschesche, H. (1998). Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases. FEBS LETTERS, 436(2), 209-212.
Krumme, D., Wenzel, H., and Tschesche, H. (1998). Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases. FEBS LETTERS 436, 209-212.
Krumme, D., Wenzel, H., & Tschesche, H., 1998. Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases. FEBS LETTERS, 436(2), p 209-212.
D. Krumme, H. Wenzel, and H. Tschesche, “Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases”, FEBS LETTERS, vol. 436, 1998, pp. 209-212.
Krumme, D., Wenzel, H., Tschesche, H.: Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases. FEBS LETTERS. 436, 209-212 (1998).
Krumme, D, Wenzel, Herbert, and Tschesche, Harald. “Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases”. FEBS LETTERS 436.2 (1998): 209-212.
This data publication is cited in the following publications:
This publication cites the following data publications:

10 Citations in Europe PMC

Data provided by Europe PubMed Central.

Novel biodegradable, biomimetic and functionalised polymer scaffolds to prevent expansion of post-infarct left ventricular remodelling.
Cristallini C, Gagliardi M, Barbani N, Giannessi D, Guerra GD., J Mater Sci Mater Med 23(1), 2012
PMID: 22143909
Rational design of tropoelastin peptide-based inhibitors of metalloproteinases.
Jensen SA, Andersen P, Vrhovski B, Weiss AS., Arch. Biochem. Biophys. 409(2), 2003
PMID: 12504900
Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.
Krumme D, Tschesche H., Bioorg. Med. Chem. Lett. 12(6), 2002
PMID: 11958997
General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.
Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierre A, Atassi G, Bonnet J, Casara P., Bioorg. Med. Chem. Lett. 11(3), 2001
PMID: 11212095
Determination of matrix metalloproteinase activity using biotinylated gelatin.
Ratnikov B, Deryugina E, Leng J, Marchenko G, Dembrow D, Strongin A., Anal. Biochem. 286(1), 2000
PMID: 11038285

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 9781680
PubMed | Europe PMC

Search this title in

Google Scholar